Vakrangee Q1 FY27: Profit Growth Masks Persistent Revenue Decline

3 hours ago
share
Share Via
Vakrangee Ltd., the Mumbai-based software and consulting services provider, reported consolidated net profit of ₹2.61 crores for Q1 FY27, marking a sequential improvement of 28.57% from ₹2.03 crores in the previous quarter. However, this profit recovery comes against a backdrop of persistent revenue weakness, with net sales declining 18.77% year-on-year to ₹55.92 crores—the lowest quarterly revenue in recent periods.
Vakrangee Q1 FY27: Profit Growth Masks Persistent Revenue Decline

The stock has struggled significantly in recent times, trading at ₹5.98 as of July 30, 2026, down 35.70% over the past year and substantially underperforming its sector benchmark. With a market capitalisation of ₹647.75 crores, the micro-cap company faces mounting pressure to demonstrate sustainable revenue growth whilst maintaining the profitability improvements seen in the latest quarter.

Consolidated Net Profit (Q1 FY27)
₹2.61 Cr
▲ 28.57% QoQ
▼ 18.18% YoY
Net Sales (Q1 FY27)
₹55.92 Cr
▼ 1.45% QoQ
▼ 18.77% YoY
Operating Margin (Excl OI)
11.86%
▲ 343 bps QoQ
PAT Margin
4.04%
▲ 118 bps QoQ

The quarterly results present a mixed narrative: whilst profitability metrics have improved sequentially, the company continues to grapple with contracting revenues. Net sales of ₹55.92 crores in Q1 FY27 represent not only a year-on-year decline of 18.77% but also a sequential decline of 1.45% from the previous quarter's ₹56.74 crores. This marks the lowest quarterly revenue figure in the recent trend, raising concerns about demand conditions and competitive positioning.

Quarter Net Sales (₹ Cr) QoQ Change Cons. Net Profit (₹ Cr) QoQ Change PAT Margin
Jun'26 55.92 ▼ 1.45% 2.61 ▲ 28.57% 4.04%
Mar'26 56.74 ▼ 5.59% 2.03 ▼ 36.36% 2.86%
Dec'25 60.10 ▼ 13.00% 3.19 ▲ 11.54% 5.24%
Sep'25 69.08 ▲ 0.35% 2.86 ▼ 10.34% 4.39%
Jun'25 68.84 ▲ 8.96% 3.19 ▲ 25.59% 4.82%
Mar'25 63.18 ▼ 6.92% 2.54 ▲ 113.45% 3.99%
Dec'24 67.88 1.19 1.55%

Financial Performance: Margin Expansion Amidst Revenue Contraction

The most striking aspect of Q1 FY27 results is the divergence between revenue and profitability trends. Operating profit before depreciation, interest, and tax (excluding other income) stood at ₹6.63 crores, translating to an operating margin of 11.86%—a significant improvement of 343 basis points from the previous quarter's 8.42%. This margin expansion reflects improved cost management, particularly in employee costs which declined to ₹9.63 crores from ₹11.04 crores sequentially.

On a standalone basis, net profit for Q1 FY27 was ₹2.26 crores, representing a sequential increase of 39.51% from ₹1.62 crores in Q4 FY26. However, the year-on-year comparison reveals persistent challenges, with standalone profit down 31.93% from ₹3.32 crores in the corresponding quarter of the previous year. The profit after tax margin improved to 4.04% from 2.86% sequentially, though it remains below the 4.82% achieved in June 2025.

Operating Profit (Excl OI)
₹6.63 Cr
Margin: 11.86%
Employee Costs
₹9.63 Cr
▼ 12.77% QoQ
Interest Burden
₹0.39 Cr
Minimal
Tax Rate
38.42%
Q1 FY27

The company's tax rate for the quarter stood at 38.42%, significantly higher than the 26.03% in the previous quarter and above the historical average of 26.75%. This elevated tax burden constrained the translation of profit before tax improvements into bottom-line gains. Profit before tax reached ₹3.67 crores, up 67.58% sequentially, but the higher tax incidence limited net profit growth to 39.51%.

Quality of Earnings Concern

High Dependence on Other Income: Other income of ₹1.98 crores constituted 53.66% of profit before tax in Q1 FY27, indicating that more than half of pre-tax profits came from non-operating sources. This raises questions about the sustainability of earnings and the core operating performance of the business. The company's profit before tax excluding other income stood at just ₹1.71 crores, representing a concerning decline of 19.80% compared to the previous four-quarter average.

Operational Challenges: Revenue Decline Continues Unabated

The fundamental challenge facing Vakrangee remains its inability to arrest the decline in top-line growth. Net sales have contracted consistently, with Q1 FY27's ₹55.92 crores representing the lowest quarterly revenue in recent periods. This 18.77% year-on-year decline follows a pattern of persistent revenue weakness, with the company's five-year sales growth rate standing at a negative 4.11% annually.

The revenue contraction becomes even more pronounced when examining the longer-term trend. From a peak of ₹685.00 crores in FY20, annual revenues have declined to ₹255.00 crores in FY25—a staggering 62.77% reduction over five years. Whilst the company achieved 20.30% revenue growth in FY25 compared to FY24, this growth appears to have stalled in the current fiscal year, with Q1 FY27 showing a return to declining sales.

Despite these revenue headwinds, the company has maintained reasonable profitability through cost discipline. Return on equity stood at 21.22% on average over recent periods, though the latest quarterly annualised ROE has declined to 5.26%. This substantial reduction in return on equity reflects both the profit volatility and the challenges in generating consistent returns from the deployed capital base.

Balance Sheet Strength: A Silver Lining

Vakrangee maintains a robust balance sheet with minimal debt and no promoter pledging. The company had shareholder funds of ₹202.44 crores as of March 2025, with long-term debt completely eliminated from the ₹7.60 crores position a year earlier. The net debt to equity ratio stands at negative 0.25, indicating the company is a net cash entity. This financial flexibility provides a cushion to weather the current operational challenges and potentially invest in growth initiatives.

Industry Context: Underperformance Against Sector Peers

Vakrangee operates in the highly competitive computers—software and consulting sector, where technological disruption and evolving client demands create both opportunities and challenges. The company's performance must be viewed against the backdrop of sector dynamics, where digital transformation initiatives across industries have driven demand for software and consulting services.

However, Vakrangee has significantly underperformed its sector benchmark, with the stock declining 35.70% over the past year compared to the sector's 14.06% decline. This 21.64 percentage point underperformance suggests company-specific challenges beyond broader sector headwinds. The stock's three-year return of negative 61.98% contrasts sharply with the Sensex's positive 17.37% return over the same period, highlighting the magnitude of value destruction.

Company P/E Ratio (TTM) P/BV Ratio ROE (%) Debt/Equity
Vakrangee 59.21x 3.11x 21.22% -0.25
Veefin Solutions 34.76x 1.35x 3.43% 0.14
Xchanging Solutions 12.70x 1.91x 9.58% -0.61
Kellton Tech 8.24x 0.93x 14.15% 0.19
Innovana Thinklabs 17.85x 2.50x 38.31% 0.17
Ksolves India 17.93x 22.65x 126.25% -0.05

The peer comparison reveals Vakrangee's valuation premium despite operational challenges. Trading at a price-to-earnings ratio of 59.21 times trailing twelve-month earnings, Vakrangee commands a significant premium to most peers, with the exception of Veefin Solutions. This valuation appears stretched given the company's negative revenue growth trajectory and declining profitability trends. The sector median P/E ratio stands at approximately 18 times, suggesting Vakrangee trades at more than three times the sector average.

Valuation Analysis: Premium Pricing for Uncertain Prospects

Vakrangee's current valuation metrics raise significant concerns about the risk-reward proposition for investors. At ₹5.98 per share, the stock trades at 59.21 times trailing earnings—a substantial premium that appears unjustified given the fundamental challenges facing the business. The price-to-book value ratio of 3.11 times, whilst lower than some peers, still represents a meaningful premium to book value for a company experiencing revenue decline.

The company's enterprise value to EBITDA multiple of 22.12 times and EV to sales ratio of 2.40 times further underscore the premium valuation. These multiples would be more appropriate for a high-growth company with expanding margins, rather than one experiencing persistent revenue contraction. The PEG ratio of 0.86, whilst appearing attractive on the surface, is misleading given the negative long-term growth rates.

P/E Ratio (TTM)
59.21x
vs Industry: 21x
Price to Book
3.11x
Book Value: ₹1.64
EV/EBITDA
22.12x
Premium Multiple
Market Cap
₹648 Cr
Micro Cap

The stock's valuation grade has fluctuated between "Expensive" and "Very Expensive" over recent months, currently sitting in the "Expensive" category. This assessment reflects the disconnect between the company's operational performance and its market valuation. With the stock trading 38.79% below its 52-week high of ₹9.77 but still 28.88% above its 52-week low of ₹4.64, there remains significant downside risk if operational performance fails to improve.

Shareholding Pattern: Stable Base with Limited Institutional Interest

The shareholding pattern reveals a stable promoter base and minimal institutional participation. Promoter holding has remained constant at 40.05% over the past five quarters, with no pledging of shares—a positive indicator of promoter confidence and financial stability. The absence of pledged shares eliminates concerns about potential margin calls or forced selling pressure.

Quarter Promoter % FII % MF % Insurance % Non-Inst %
Jun'26 40.05% 0.35% 0.00% 4.05% 55.55%
Mar'26 40.05% 0.45% 0.00% 4.13% 55.36%
Dec'25 40.05% 0.49% 0.00% 4.45% 55.01%
Sep'25 40.05% 0.82% 0.00% 4.47% 54.66%
Jun'25 40.05% 2.73% 0.00% 4.47% 52.74%

However, the shareholding pattern also reveals concerning trends in institutional participation. Foreign institutional investor (FII) holding has declined sharply from 2.73% in June 2025 to just 0.35% in June 2026—a reduction of 238 basis points over four quarters. This sustained selling by sophisticated foreign investors suggests diminishing confidence in the company's prospects. The complete absence of mutual fund holdings (0.00% across all periods) further underscores the lack of institutional interest.

Insurance company holdings have also declined modestly from 4.47% to 4.05% over the past year. The increase in non-institutional holdings from 52.74% to 55.55% reflects retail investor participation, though this has largely filled the void left by exiting institutional investors. With total institutional holdings at just 4.40%, the stock lacks the anchor investors typically associated with stable, quality companies.

Stock Performance: Severe Underperformance Across All Timeframes

Vakrangee's stock price performance has been dismal across virtually all timeframes, reflecting the market's assessment of the company's deteriorating fundamentals. The stock declined 1.81% on July 30, 2026, closing at ₹5.98 after opening at ₹6.08. Trading below all key moving averages—from the 5-day moving average of ₹5.96 to the 200-day moving average of ₹7.00—the stock exhibits clear technical weakness.

Period Vakrangee Return Sensex Return Alpha
1 Week +3.82% +1.65% +2.17%
1 Month -1.81% +1.53% -3.34%
3 Months -13.46% +0.96% -14.42%
6 Months -13.96% -5.61% -8.35%
YTD -23.63% -8.88% -14.75%
1 Year -35.70% -4.70% -31.00%
2 Years -72.64% -4.67% -67.97%
3 Years -61.98% +17.37% -79.35%

The returns analysis reveals catastrophic wealth destruction over longer periods. Over three years, the stock has declined 61.98% whilst the Sensex gained 17.37%—a staggering negative alpha of 79.35 percentage points. The two-year return of negative 72.64% and five-year return of negative 81.34% underscore the magnitude of value erosion. Investors who purchased shares five years ago have lost more than four-fifths of their investment.

The stock's beta of 1.58 indicates it is significantly more volatile than the broader market, amplifying both gains and losses. However, with consistently negative returns, this high beta has worked entirely against investors. The risk-adjusted return of negative 0.88 over the past year, combined with volatility of 40.35%, places the stock firmly in the "High Risk Low Return" category—an unfavourable combination for any investment.

"With revenue declining 18.77% year-on-year to the lowest quarterly level in recent periods, and trading at 59 times earnings despite negative long-term growth, Vakrangee presents a challenging investment case that demands concrete evidence of operational turnaround."

Investment Thesis: Quality Concerns Outweigh Balance Sheet Strength

Vakrangee's investment thesis rests on several conflicting pillars. On the positive side, the company maintains a debt-free balance sheet with no promoter pledging, strong interest coverage of 31.90 times on average, and reasonable return on equity of 21.22% over recent periods. These factors contribute to its "Average" quality grade, suggesting the company possesses some fundamental strengths.

However, these positives are overshadowed by significant structural challenges. The five-year sales growth rate of negative 4.11% and EBIT growth rate of negative 5.22% indicate persistent business contraction rather than temporary cyclical weakness. The latest quarter's financial trend is classified as "Flat," with Q1 FY27 revenue hitting the lowest level in recent periods. The concerning dependence on other income, which constituted 53.66% of profit before tax, raises questions about the sustainability of reported profitability.

Valuation Grade
EXPENSIVE
P/E: 59x
Quality Grade
AVERAGE
Mixed Signals
Financial Trend
FLAT
Q1 FY27
Technical Trend
MILDLY BEARISH
Below all MAs

The technical picture reinforces the fundamental concerns. The stock trades in a "Mildly Bearish" trend, below all major moving averages, with multiple technical indicators flashing bearish or mildly bearish signals. The combination of expensive valuation (trading at 59 times earnings versus industry average of 21 times), flat-to-negative financial trends, and bearish technicals creates a challenging environment for investors.

Key Strengths & Risk Factors

KEY STRENGTHS

  • Debt-Free Balance Sheet: Zero long-term debt with net cash position (debt-to-equity of -0.25), providing financial flexibility
  • No Promoter Pledging: Stable 40.05% promoter holding with zero pledged shares demonstrates promoter confidence
  • Strong Interest Coverage: Average EBIT to interest ratio of 31.90 times indicates robust debt servicing capability
  • Margin Improvement: Operating margin expanded to 11.86% in Q1 FY27 from 8.42% in previous quarter
  • Reasonable ROE: Average return on equity of 21.22% demonstrates decent capital efficiency over time
  • Sequential Profit Growth: Consolidated net profit up 28.57% quarter-on-quarter to ₹2.61 crores
  • Cost Discipline: Employee costs reduced by 12.77% sequentially, showing management focus on efficiency

KEY CONCERNS

  • Persistent Revenue Decline: Net sales down 18.77% YoY to ₹55.92 crores—lowest quarterly revenue in recent periods
  • Negative Long-Term Growth: Five-year sales CAGR of -4.11% and EBIT CAGR of -5.22% indicate structural challenges
  • High Other Income Dependence: Other income constitutes 53.66% of PBT, raising sustainability concerns
  • Expensive Valuation: P/E of 59x versus industry average of 21x appears unjustified given negative growth
  • Institutional Exodus: FII holding declined from 2.73% to 0.35%; zero mutual fund presence
  • Severe Stock Underperformance: Down 35.70% over one year; 72.64% over two years with negative alpha across all periods
  • Declining ROE: Latest quarterly ROE of 5.26% substantially below historical average of 21.22%

Outlook: What Lies Ahead

The forward outlook for Vakrangee hinges on the company's ability to arrest revenue decline and demonstrate sustainable profit growth from core operations. Management's focus on cost optimisation has yielded margin improvements, but without top-line growth, the company faces limited prospects for meaningful earnings expansion. The software and consulting sector offers opportunities from digital transformation initiatives, but Vakrangee must articulate a clear strategy to capture market share.

POSITIVE CATALYSTS

  • Sustained margin expansion through operational efficiency
  • Return to revenue growth in upcoming quarters
  • Reduction in dependence on other income
  • Institutional investor interest revival

RED FLAGS TO MONITOR

  • Further quarter-on-quarter revenue decline
  • Continued high dependence on non-operating income
  • Additional FII or insurance company stake reductions
  • Failure to maintain margin improvements

Key monitoring points include quarterly revenue trends, the sustainability of margin improvements, and any signs of institutional investor interest returning. The company's ability to reduce dependence on other income whilst growing operating profits will be critical to rebuilding investor confidence. Technical indicators suggest limited near-term upside, with resistance at the ₹6.01 level (20-day moving average) and more significant resistance at ₹7.00 (200-day moving average).

The Verdict: Operational Turnaround Required Before Investment Consideration

SELL

Score: 37/100

For Fresh Investors: Avoid initiating positions at current valuations. The combination of persistent revenue decline, expensive valuation (59x earnings), and bearish technical trends creates an unfavourable risk-reward profile. Wait for concrete evidence of revenue stabilisation and sustainable profit growth from core operations before considering investment.

For Existing Holders: Consider reducing exposure on any technical rallies towards the ₹6.50-7.00 zone. Whilst the debt-free balance sheet provides some downside protection, the lack of revenue growth visibility and institutional selling pressure suggest limited near-term catalysts. Re-evaluate holdings if the company demonstrates two consecutive quarters of revenue growth with improving operating metrics.

Fair Value Estimate: ₹4.50 (24.75% downside from current price of ₹5.98). This valuation assumes normalised earnings and a more reasonable P/E multiple of 25-30x aligned with sector averages, conditional upon revenue stabilisation.

Rationale: Despite sequential profit improvement and a strong balance sheet, Vakrangee's persistent revenue decline (down 18.77% YoY to the lowest quarterly level), expensive valuation (59x P/E versus 21x industry average), and exodus of institutional investors create a challenging investment case. The high dependence on other income (53.66% of PBT) and negative five-year growth rates (-4.11% sales CAGR) indicate structural rather than cyclical challenges. Until the company demonstrates sustainable revenue growth and reduced reliance on non-operating income, the risk-reward remains unfavourable.

Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Stock prices are subject to market risks and volatility.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are Vakrangee Ltd latest results good or bad?
Jul 29 2026 07:19 PM IST
share
Share Via
Vakrangee Ltd is Rated Sell
Jul 29 2026 10:11 AM IST
share
Share Via
Vakrangee Ltd Technical Momentum Shifts Amid Bearish Trend
Jul 29 2026 08:01 AM IST
share
Share Via
Vakrangee Ltd is Rated Sell
Jul 18 2026 10:10 AM IST
share
Share Via
Vakrangee Ltd is Rated Sell
Jul 07 2026 10:10 AM IST
share
Share Via
Vakrangee Ltd is Rated Sell by MarketsMOJO
Jun 26 2026 10:10 AM IST
share
Share Via